Sanctuary Advisors LLC Cuts Position in Haleon plc (NYSE:HLN)

Sanctuary Advisors LLC lessened its holdings in Haleon plc (NYSE:HLN) by 2.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 239,879 shares of the company’s stock after selling 5,431 shares during the period. Sanctuary Advisors LLC’s holdings in Haleon were worth $2,296,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Sierra Ocean LLC purchased a new position in shares of Haleon in the 4th quarter valued at about $26,000. Fortitude Family Office LLC purchased a new stake in Haleon during the 3rd quarter worth approximately $28,000. Versant Capital Management Inc increased its stake in Haleon by 2,029.1% during the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after buying an additional 3,348 shares in the last quarter. Geneos Wealth Management Inc. purchased a new stake in Haleon during the 4th quarter worth approximately $35,000. Finally, Toronto Dominion Bank increased its stake in Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after buying an additional 3,470 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on HLN. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Haleon currently has a consensus rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Trading Up 1.8 %

Shares of Haleon stock opened at $10.08 on Friday. The stock has a market cap of $45.61 billion, a P/E ratio of 29.63, a P/E/G ratio of 2.82 and a beta of 0.28. The stock’s 50 day simple moving average is $9.56 and its 200-day simple moving average is $9.82. Haleon plc has a 1-year low of $7.89 and a 1-year high of $10.80. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.